171 related articles for article (PubMed ID: 6059731)
21. [Rarefying osteopathy in rheumatology. Methods of evaluation and comparison of urinary hydroxyproline and serum proline iminopeptidase].
D'Amore M; Quarto S; Terlizzi N; Martiradonna A; Carrozzo M
Minerva Med; 1980 Jul; 71(29):2045-51. PubMed ID: 6967571
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases.
Robins SP; Black D; Paterson CR; Reid DM; Duncan A; Seibel MJ
Eur J Clin Invest; 1991 Jun; 21(3):310-5. PubMed ID: 1909635
[TBL] [Abstract][Full Text] [Related]
23. Effects of calcium infusion on urinary hydroxyproline and phosphorus: evaluation as a diagnostic test.
Bell NH; Colwell JA; Saval F; Del Greco F; Casey DE
J Clin Endocrinol Metab; 1966 Jul; 26(7):677-82. PubMed ID: 5917031
[No Abstract] [Full Text] [Related]
24. Hydroxyproline.
Niejadlik DC
Postgrad Med; 1972 May; 51(5):213-6. PubMed ID: 5025220
[No Abstract] [Full Text] [Related]
25. [On the excretion of bound hydroxyproline as an expression of changes in the organic cartilage and bone matrix].
Mühlbach R; Hirthe D; Lindenhayn K
Z Arztl Fortbild (Jena); 1966 May; 60(10):597-602. PubMed ID: 5997685
[No Abstract] [Full Text] [Related]
26. Total urinary hydroxyproline in primary hyperparathyroidism. An assessment of its clinical significance.
Smith R
Clin Chim Acta; 1967 Oct; 18(1):47-50. PubMed ID: 6064692
[No Abstract] [Full Text] [Related]
27. [Clinical significance of the determination of hydroxyprolinuria].
Ruiz-Torres A
Med Welt; 1969 Oct; 40():2176-80. PubMed ID: 5355662
[No Abstract] [Full Text] [Related]
28. [Significance of hydroxyproline analysis in clinical tests].
Igarashi S
Nihon Rinsho; 1989 Dec; 48 Suppl():425-7. PubMed ID: 2621916
[No Abstract] [Full Text] [Related]
29. [Urinary excretion of hydroxyproline in acromegaly (author's transl)].
Lepszy H; Irmscher K; Wiegelmann W; Solbach HG; Krüskemper HL
Dtsch Med Wochenschr; 1976 May; 101(22):857-61. PubMed ID: 1269418
[TBL] [Abstract][Full Text] [Related]
30. Studies on urinary hydroxyproline.
Ogane S
Fukushima J Med Sci; 1969 May; 15(3):97-109. PubMed ID: 5262427
[No Abstract] [Full Text] [Related]
31. The relationship of the serum alkaline phosphatase to urinary hydroxyproline excretion in liver and bone diseases.
Cerda JJ; Toskes PP; Shopa NA; Wilkinson JH
Clin Chim Acta; 1970 Mar; 27(3):437-43. PubMed ID: 5461604
[No Abstract] [Full Text] [Related]
32. Clinical applications of urinary hydroxyproline determination.
Laitinen O
Acta Med Scand Suppl; 1975; 577():1-57. PubMed ID: 1057370
[No Abstract] [Full Text] [Related]
33. Correlation of serum, bone and urinary hydroxyproline in nutritional osteomalacia.
Rizvi SN; Vaishnava H
J Assoc Physicians India; 1973 Feb; 21(2):189-93. PubMed ID: 4792789
[No Abstract] [Full Text] [Related]
34. [Urinary hydroxyproline and the metabolism of collagen].
Kivirikko KI
Duodecim; 1969; 85(18):1108-19. PubMed ID: 5371391
[No Abstract] [Full Text] [Related]
35. [Urinary excretion of hydroxyproline in thyroid diseases].
Siersbaek-Nielsen K; Skovsted L; Molholm Hansen J; Kristensen M; Korsgaard Christensen L
Ugeskr Laeger; 1971 Mar; 133(11):491-3. PubMed ID: 5553235
[No Abstract] [Full Text] [Related]
36. [Urinary excretion of hydroxyproline in hyperthyroidism].
Conte N; Scandellari C; Guido R
Omnia Med Ther; 1970; 48(4):497-506. PubMed ID: 5520244
[No Abstract] [Full Text] [Related]
37. Urinary hydroxyproline excretion in orthopedic disease, with special reference to systemic bone disease and bone tumor (secondary report).
Nakagawa M; Sugiura Y; Oshima T; Kajino G; Hirako H
Nagoya J Med Sci; 1967 Mar; 29(4):345-67. PubMed ID: 6066099
[No Abstract] [Full Text] [Related]
38. A detailed study of the urinary peptides in a patient with osteomalacia and hyperparathyroidism.
Cahill R; Smith R; Westall RG
Clin Sci; 1970 Apr; 38(4):519-32. PubMed ID: 5428813
[No Abstract] [Full Text] [Related]
39. Investigation of bone disease using isomerized and racemized fragments of type I collagen.
Cloos PA; Fledelius C; Christgau S; Christiansen C; Engsig M; Delmas P; Body JJ; Garnero P
Calcif Tissue Int; 2003 Jan; 72(1):8-17. PubMed ID: 12384813
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in the unerstanding and management of metabolic bone disease.
Smith R
Proc R Soc Med; 1970 Sep; 63(9):931-4. PubMed ID: 4921479
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
